Notably, ramalin treatment significantly reduced the phosphorylated forms of JNK, ERK, and, to a lesser extent, p38 MAPK in both 3xTg‐AD and APP/PS1 mouse brains. This evidence concerns the gene APP and Alzheimer disease.